• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Campbell Appoints Carrie Anderson Chief Financial Officer

    1/25/23 4:30:00 PM ET
    $CPB
    $EMBC
    $IART
    Packaged Foods
    Consumer Staples
    Medical/Dental Instruments
    Health Care
    Get the next $CPB alert in real time by email

    Campbell Soup Company (NYSE:CPB) today announced the appointment of Carrie L. Anderson as Executive Vice President and Chief Financial Officer, effective Feb. 6.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230125005725/en/

    Carrie Anderson (Photo: Business Wire)

    Carrie Anderson (Photo: Business Wire)

    Anderson will lead Campbell's finance function, including controllership, corporate financial planning and analysis, corporate strategy and development, tax, treasury, internal audit, investor relations, transactional services and financial systems. She will report to Campbell's President and Chief Executive Officer Mark Clouse and become a member of the company's Operating Committee and a Corporate Officer. Anderson succeeds Mick Beekhuizen, who was appointed President of Campbell's Meals & Beverages division in November 2022.

    "I am delighted to welcome Carrie to our leadership team. She brings a wide range of diverse, strategic experience and financial discipline, and her expertise in capital management and deployment will help us continue to drive our growth plans and enhance our performance," said Clouse. "Her collaborative approach combined with a track record of driving transformation, delivering results and developing strong finance teams will be invaluable as we continue to build momentum in the business."

    Anderson brings a wealth of financial experience working in a variety of complex industries, as well as a background in manufacturing and engineering. She joins Campbell from Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, where she has served as Executive Vice President and Chief Financial Officer since 2019. Before Integra, Anderson spent seven years with Dover Corporation in several leadership roles, including Chief Accounting Officer/Corporate Controller, and Vice President and CFO for the company's engineered systems and printing and identification businesses. Previously, Anderson spent six years as Vice President and Chief Financial Officer of Delphi Product & Service Solutions, a division of Delphi Corporation. While at Delphi, she also held leadership positions in finance, treasury and investor relations. Anderson started her career with General Motors.

    Anderson earned her B.S. in chemical engineering from Purdue University and an MBA from Ball State University. She serves on the board of directors of Embecta Corp. (NASDAQ:EMBC) and is a member of its Audit and Nominating & Governance committees.

    About Campbell Soup Company

    For more than 150 years, Campbell (NYSE:CPB) has been connecting people through food they love. Generations of consumers have trusted Campbell to provide delicious and affordable food and beverages. Headquartered in Camden, N.J. since 1869, Campbell generated fiscal 2022 net sales of nearly $8.6 billion. Our portfolio includes iconic brands such as Campbell's, Cape Cod, Goldfish, Kettle Brand, Lance, Late July, Milano, Pace, Pacific Foods, Pepperidge Farm, Prego, Snyder's of Hanover, Swanson and V8. Campbell has a heritage of giving back and acting as a good steward of the environment. The company is a member of the Standard & Poor's 500 as well as the FTSE4Good and Bloomberg Gender-Equality Indices. For more information, visit www.campbellsoupcompany.com or follow company news on Twitter via @CampbellSoupCo.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005725/en/

    Get the next $CPB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CPB
    $EMBC
    $IART

    CompanyDatePrice TargetRatingAnalyst
    The Campbell's Company
    $CPB
    6/3/2026$19.00Mkt Perform → Underperform
    Bernstein
    The Campbell's Company
    $CPB
    6/1/2026$21.00Overweight → Equal-Weight
    Stephens
    Integra LifeSciences Holdings Corporation
    $IART
    5/28/2026$16.00Sell → Neutral
    Citigroup
    Embecta Corp.
    $EMBC
    5/6/2026Buy → Neutral
    BTIG Research
    The Campbell's Company
    $CPB
    4/27/2026$21.00Outperform → Mkt Perform
    Bernstein
    Integra LifeSciences Holdings Corporation
    $IART
    4/15/2026Buy → Hold
    Argus
    The Campbell's Company
    $CPB
    4/14/2026Neutral
    BTIG Research
    The Campbell's Company
    $CPB
    3/12/2026$20.00Equal Weight → Underweight
    Wells Fargo
    More analyst ratings

    $CPB
    $EMBC
    $IART
    SEC Filings

    View All

    SEC Form SD filed by Integra LifeSciences Holdings Corporation

    SD - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Filer)

    5/29/26 4:42:09 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Embecta Corp.

    SCHEDULE 13G/A - Embecta Corp. (0001872789) (Subject)

    5/27/26 11:25:39 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    SEC Form SD filed by Embecta Corp.

    SD - Embecta Corp. (0001872789) (Filer)

    5/22/26 10:37:03 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Soup Just Got a Wingman: New Campbell's® Chunky® Buffalo Wild Wings® Parmesan Garlic Chicken Noodle Soup

    A wing lover's favorite is now available in the soup aisle Campbell's Chunky, known for its hearty, flavor-packed soups, is teaming up with Buffalo Wild Wings, the largest sports bar brand in the United States and a rapidly growing off-premise business through Buffalo Wild Wings GO, on a new mouthwatering collaboration: Campbell's Chunky Buffalo Wild Wings Parmesan Garlic Chicken Noodle Soup. The new offering delivers a rich, creamy twist on a fan favorite – Chunky Classic Chicken Noodle soup – by pairing it with BWW's signature Parmesan Garlic flavor. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603950072/en/Campbell's C

    6/3/26 9:00:00 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts

    Issued on behalf of Conexeu Sciences Inc.A newly listed regenerative-tissue company has put its lead breast-reconstruction matrix on the bench at one of the world's largest bioprinting institutes. For investors tracking the space, the partner it chose may matter more than anything it has said.Equity Insider Market CommentaryTAMPA, Fla., June 2, 2026 /CNW/ -- For more than half a century, the answer to lost tissue has been to manufacture a substitute and put it where the tissue used to be. Replace, don't restore. That logic built the modern implant industry, and it works — up to a point. But it leaves a gap, and the gap shows up in the numbers: roughly two-thirds of the more than 100,000 wome

    6/2/26 9:00:00 AM ET
    $BVS
    $IART
    $MDXG
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference

    PRINCETON, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that chief financial officer Lea Knight will present at the 2026 Jefferies Global Healthcare Conference on June 3, 2026 at 10:30am ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website under EVENTS & PRESENTATIONS. About Integra LifeSciencesIntegra LifeSciences (NASDAQ:IART) is a global medical technology leader dedicated to restoring lives. We are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fi

    6/2/26 7:30:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $CPB
    $EMBC
    $IART
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CPB
    $EMBC
    $IART
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Graves Jeffrey A bought $102,150 worth of shares (9,000 units at $11.35), increasing direct ownership by 28% to 41,086 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    11/6/25 4:05:46 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    5/23/25 4:35:56 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $177,646 worth of shares (13,000 units at $13.67), increasing direct ownership by 20% to 76,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    2/25/25 4:26:16 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    The Campbell's Company downgraded by Bernstein with a new price target

    Bernstein downgraded The Campbell's Company from Mkt Perform to Underperform and set a new price target of $19.00

    6/3/26 8:07:10 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    The Campbell's Company downgraded by Stephens with a new price target

    Stephens downgraded The Campbell's Company from Overweight to Equal-Weight and set a new price target of $21.00

    6/1/26 8:46:31 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Integra upgraded by Citigroup with a new price target

    Citigroup upgraded Integra from Sell to Neutral and set a new price target of $16.00

    5/28/26 8:44:41 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by EVP & Chief Commercial Officer Mcbreen Michael J.

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    6/3/26 4:58:41 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by President and CEO Essig Stuart

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    6/3/26 4:54:58 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    VP, Chief Accounting Officer Roth Anthony M. was granted 30,000 shares, increasing direct ownership by 61% to 78,833 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    6/2/26 5:02:51 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Leadership Updates

    Live Leadership Updates

    View All

    Soup Just Got a Wingman: New Campbell's® Chunky® Buffalo Wild Wings® Parmesan Garlic Chicken Noodle Soup

    A wing lover's favorite is now available in the soup aisle Campbell's Chunky, known for its hearty, flavor-packed soups, is teaming up with Buffalo Wild Wings, the largest sports bar brand in the United States and a rapidly growing off-premise business through Buffalo Wild Wings GO, on a new mouthwatering collaboration: Campbell's Chunky Buffalo Wild Wings Parmesan Garlic Chicken Noodle Soup. The new offering delivers a rich, creamy twist on a fan favorite – Chunky Classic Chicken Noodle soup – by pairing it with BWW's signature Parmesan Garlic flavor. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603950072/en/Campbell's C

    6/3/26 9:00:00 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    A. O. Smith Announces Retirement of Charles T. Lauber and Appointment of Carrie L. Anderson as Executive Vice President and Chief Financial Officer

    MILWAUKEE, May 19, 2026 /PRNewswire/ -- A. O. Smith Corporation (NYSE:AOS), a leader in water heating and water treatment, announced today that Carrie L. Anderson will become the company's next executive vice president and chief financial officer on July 1. She succeeds Charles T. Lauber, who will retire from the company after serving in different senior leadership capacities for over 26 years. He will remain at the company through Sept. 30 to ensure continuity during the transition. Anderson will serve as a key member of A. O. Smith's executive leadership team and lead the company's finance organization responsible for strategic financial planning, capital allocation, treasury, controllersh

    5/19/26 4:15:00 PM ET
    $AOS
    $CPB
    Consumer Electronics/Appliances
    Consumer Discretionary
    Packaged Foods
    Consumer Staples

    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

    MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company"), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced the appointment of Dan Reuvers as the Company's next President and Chief Executive Officer, effective March 23, 2026. Mr. Reuvers will also join the Board of Directors at that time. He succeeds Keith Sullivan, who will step down as the Company's President and Chief Executive Officer on March 23, 2026 and retire on March 31, 2026 after five and a half years of leadin

    3/17/26 7:45:00 AM ET
    $IART
    $STIM
    $TCMD
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Integra LifeSciences Holdings Corporation

    SC 13G - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 5:20:30 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Integra LifeSciences Holdings Corporation

    SC 13G/A - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 12:54:20 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Embecta Corp.

    SC 13G/A - Embecta Corp. (0001872789) (Subject)

    11/8/24 10:57:43 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Financials

    Live finance-specific insights

    View All

    The Campbell's Company to Report Third Quarter Fiscal 2026 Results on June 8, 2026

    The Campbell's Company (NASDAQ:CPB) (Campbell's) announced it will report its financial results for the third quarter fiscal 2026 ended May 3, 2026 on June 8, 2026. A press release, slide presentation, transcript and audio of pre-recorded management remarks will be available at 7:15 a.m. ET. Mick Beekhuizen, President and Chief Executive Officer, and Todd Cunfer, Executive Vice President and Chief Financial Officer will host a live question-and-answer session at 9:00 a.m. ET. Please visit the "Events & Presentations" section of Campbell's investor relations website at investor.thecampbellscompany.com to access these materials and the live Q&A webcast. A full transcript and replay of the

    5/19/26 7:30:00 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    The Campbell's Company Declares Quarterly Dividend

    The Board of Directors of The Campbell's Company (NASDAQ:CPB) (Campbell's) today declared a regular quarterly dividend on the company's capital stock of $0.39 per share. The quarterly dividend is payable Aug. 3, 2026, to shareholders of record at the close of business as of July 2, 2026. About The Campbell's Company For more than 155 years, The Campbell's Company (NASDAQ:CPB) (Campbell's) has been connecting people through food they love. Headquartered in Camden, N.J. since 1869, generations of consumers have trusted us to provide delicious and affordable food and beverages. Today, the company is a North American focused brand powerhouse, generating fiscal 2025 net sales of $10.3 billio

    5/13/26 5:30:00 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results

    PARSIPPANY, N.J., May 05, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today reported second quarter fiscal 2026 financial results. Visit the company's Investor Relations website at http://investors.embecta.com to view the detailed second quarter fiscal 2026 earnings press release and investor presentation. The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, May 5, 2026, which is accessible here, or access the teleconference here. The live webcast can also be accessed via the company'

    5/5/26 6:30:00 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care